← Back to all signals
RESEARCH PAPER ANALYSIS

Protocol for a Sequential Multiple Assignment Randomized Trial to Improve Physical Activity and Diet Quality in Survivors of Cancer.

This protocol describes an ongoing SMART trial in 374 adult survivors of childhood cancer testing adaptive clinician-guided, mobile health, and intensive coaching strategies to reduce sedentary time and improve diet quality over 12 months.

Open original publication →
PMID42594273
JournalJMIR research protocols
Publication Date2026-08-13
Ingested2026-08-17 12:23 AM
EXECUTIVE SUMMARY

What the AI sees

This protocol describes an ongoing SMART trial in 374 adult survivors of childhood cancer testing adaptive clinician-guided, mobile health, and intensive coaching strategies to reduce sedentary time and improve diet quality over 12 months.

WHY IT MATTERS

Research significance

The record establishes that adaptive lifestyle interventions are being tested in survivors at increased cardiovascular risk but provides no efficacy results; if the interventions improve sedentary time and Healthy Eating Index scores, they could plausibly support cardiovascular risk reduction, although effects on cardiovascular events or other clinical outcomes remain untested.

ABSTRACT

Source abstract

BACKGROUND: Survivors of childhood cancer have an increased risk of cardiovascular disease (CVD), but that risk may be reduced by healthy lifestyle behaviors. OBJECTIVE: Using a sequential multiple assignment randomized trial (SMART) design, this study aims to test different approaches to improve physical activity (PA) and diet quality among long-term survivors of cancer at increased risk of CVD over a 12-month period. The primary study outcomes are sedentary time and Healthy Eating Index (HEI) scores. METHODS: Participants were recruited from the Childhood Cancer Survivor Study cohort, with eligibility defined as current age of 18 to 54 years and at least one of three self-reported criteria: (1) <30 minutes per day of moderate to vigorous PA, (2) HEI-2015 score <60, or (3) BMI ≥25 kg/m2. Eligible participants completed baseline surveys, including a food frequency questionnaire, and had PA measured by research-grade accelerometry, and were then randomized to one of three conditions: (1) control, (2) clinician-guided action plan (sessions with the study provider every 2 months), or (3) mobile health-supported goal setting (weekly PA and monthly diet goals based on PA and diet tracker feedback). Following SMART principles, all participants' PA levels and HEI scores were reassessed after 3 months; participants from the 2 intervention groups who did not achieve ≥20-minute per day reduction in sedentary time or a ≥4-point increase in HEI score were classified as nonresponders and rerandomized to the alternative intervention or a more intensive lifestyle coaching intervention (weekly sessions with a study health coach). Intervention participants then entered a less intensive maintenance phase from months 7 to 12. All participants' PA levels and HEI scores were reassessed at 12 months. The target sample size was 375 participants, with 95 participants in the control group and 140 participants in each of the initial intervention groups, which will allow the study to detect changes of 0.35 SD (approximately 30 minutes per day) in sedentary time and 0.41 SD (approximately 4 points) in HEI score between the control and intervention groups (combined). Secondary analyses will test whether there are efficacy differences across intervention strategies, and which intervention sequences are associated with the greatest reduction in sedentary time and improvements in diet quality. RESULTS: From April 2022 to August 2025, the trial completed recruitment and randomized 374 participants out of 2268 approached. The last participant in this ongoing trial is expected to complete all procedures by the end of 2026, after which the final analyses will be conducted and the results will be reported. CONCLUSIONS: Future findings will inform whether any of these intervention strategies (and/or their combinations) can improve PA levels and diet quality in survivors of cancer at increased risk of CVD.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Effects of early menarche on adolescent health: a single-centre retrospective study. Pediatric endocrinology, diabetes, and metabolism 68.4 2 Changes in the diagnosis and management of polycystic ovary syndrome in adolescents based on recommendations of scientific societies over the last decade. Pediatric endocrinology, diabetes, and metabolism 74.8 3 Development of a Behavioral Intervention, Increasing HPV Vaccine Uptake-Delivered in Dental Settings (HPV Vaccine Uptake-DDS). Behavioral medicine (Washington, D.C.) 61.4 4 A non-inferiority randomized controlled trial comparing nebulized fentanyl and intravenous morphine for acute pain management in the emergency department. BMC emergency medicine 77.6 5 Prevalence and behavioral factors associated with penile and rectal HPV infection among men who have sex with men in Kenya. BMC infectious diseases 71.0 6 Knowledge of cervical cancer and uptake of HPV vaccine among in-school adolescent girls in Kwara State, Nigeria. Infectious agents and cancer 75.7 7 Association of coping pathways with anxiety symptoms in children with hematological cancers: a cross-sectional study using regression and fuzzy-set qualitative comparative analysis. BMC psychology 70.4 8 Clinician vs. self-assessment of mFG hirsutism scores in PCOS: can patient self-assessment serve as a reliable screening and triage tool? BMC women's health 61.5 9 Impact of Obesity on Chemotherapy Pharmacokinetics, Toxicity, and Survival Outcomes in Pediatric Acute Lymphoblastic Leukemia. Cureus 75.0 10 Head & Neck and Shoulder Desmoid-Type Fibromatosis: Presentation and Natural History of These Ultra-Rare Locations. Cancer medicine 70.7 11 Leveraging Digital Histopathology to Build Capacity and Collaboration Toward the Diagnosis of Pediatric Solid Tumors in Mexico. JCO global oncology 59.9 12 [Newborn with neurofibromatosis type 1 and meningoencephalocele]. Ugeskrift for laeger 47.5 13 Central nervous system, cranial, and cerebrovascular conditions beyond the Kimonis criteria in patients with Gorlin syndrome: a retrospective cohort study. Frontiers in neurology 67.0 14 Resistance mechanisms and translational bottlenecks in CAR-T cell therapy for pediatric acute lymphoblastic leukemia: a perspective. Frontiers in immunology 84.27 15 Gut microbiota dysbiosis in pediatric acute lymphoblastic leukemia: clinical consequences, mechanistic insights, and microbiota-targeted interventions. Frontiers in pediatrics 82.6 16 Ewing sarcoma and paediatric cancer burden: we need more robust registries. Lancet regional health. Americas 47.5 17 Health and economic benefits of air quality improvements in France through diverse net-zero transition scenarios by 2050. Environment international 57.5 18 [Assessment of myocardial injury following anthracycline chemotherapy in children with leukemia by echocardiography]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 69.64 19 Thyroid Differentiation Score as a Molecular Bridge Between Genotype, Tumor Biology, and Radioiodine Theranostics in Thyroid Cancer. Endocrine-related cancer 64.7 20 [Development and validation of a prediction model for postoperative recurrence risk of ovarian endometriotic cysts based on preoperative imaging and clinical biomarkers]. Zhonghua yi xue za zhi 71.75 21 Lactation Management in Patients With Cancer: An Evidence-Based Framework for Surgical Practice. The American surgeon 71.0 22 Evidence-Based Recommendations for School Integration Programs Following Cancer: A Systematic Review. Journal of pediatric hematology/oncology nursing 70.0 23 Discharge Planning in Children With Cancer: Components, Strategies, and Outcomes-A Scoping Review (2021-2025). Journal of pediatric hematology/oncology nursing 58.0 24 Intervention to Support Families of Survivors of Pediatric Brain Tumor: A Scoping Review. Journal of pediatric hematology/oncology nursing 72.7 25 The role of allogeneic hematopoietic stem cell transplantation in adults with mature T-cell lymphomas. The Cochrane database of systematic reviews 88.6 26 Relative frequency of non-Wilms renal tumours in children: an institutional experience from a national tertiary referral centre in Malaysia. Pediatric surgery international 63.4 27 Childhood Cancer Risk After Assisted Reproductive Technology. JAMA 50.0 28 Long-Term Outcomes and Biomarker Correlates of a Multi-Institutional Phase II Study of Hypofractionated Proton Beam Therapy for Unresectable Primary Liver Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 83.39 29 The Burden of Early-Onset Gastric Cancer From 1990 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021. Journal of clinical gastroenterology 58.0 30 Decomposing the decline in life expectancy at birth by cause of death during the COVID-19 pandemic in Canada. Health reports 38.5 31 Integrating Surgery and Immunotherapy in the Treatment of Childhood Orbital Melanoma: A Case Report and the Literature Review. Ophthalmic plastic and reconstructive surgery 62.56 32 Co-occurrence of retinoblastoma and oculocutaneous albinism in a Mexican patient: a case report. Ophthalmic genetics 51.9
PATIENT-FRIENDLY SUMMARY

Protocol for a Sequential Multiple Assignment Randomized Trial to Improve Physical Activity and Diet Quality in Survivors of Cancer.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic